- Home
- ACIU vs PSF Comparison
ACIU vs PSF Comparison
Compare ACIU & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PSF
- Stock Information
- Founded
- ACIU 2003
- PSF 2010
- Country
- ACIU Switzerland
- PSF United States
- Employees
- ACIU N/A
- PSF N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PSF Investment Managers
- Sector
- ACIU Health Care
- PSF Finance
- Exchange
- ACIU Nasdaq
- PSF Nasdaq
- Market Cap
- ACIU 294.9M
- PSF 240.4M
- IPO Year
- ACIU 2016
- PSF N/A
- Fundamental
- Price
- ACIU $2.65
- PSF $20.11
- Analyst Decision
- ACIU Strong Buy
- PSF
- Analyst Count
- ACIU 2
- PSF 0
- Target Price
- ACIU $12.00
- PSF N/A
- AVG Volume (30 Days)
- ACIU 147.0K
- PSF 25.0K
- Earning Date
- ACIU 03-13-2025
- PSF 01-01-0001
- Dividend Yield
- ACIU N/A
- PSF 7.69%
- EPS Growth
- ACIU N/A
- PSF N/A
- EPS
- ACIU N/A
- PSF N/A
- Revenue
- ACIU $48,505,404.00
- PSF N/A
- Revenue This Year
- ACIU $86.72
- PSF N/A
- Revenue Next Year
- ACIU $118.28
- PSF N/A
- P/E Ratio
- ACIU N/A
- PSF N/A
- Revenue Growth
- ACIU 4097200.00
- PSF N/A
- 52 Week Low
- ACIU $2.25
- PSF $16.00
- 52 Week High
- ACIU $4.98
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- ACIU 39.10
- PSF 55.94
- Support Level
- ACIU $2.56
- PSF $19.41
- Resistance Level
- ACIU $2.83
- PSF $20.18
- Average True Range (ATR)
- ACIU 0.16
- PSF 0.20
- MACD
- ACIU -0.00
- PSF 0.05
- Stochastic Oscillator
- ACIU 16.85
- PSF 89.74
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.